FGFR1 Amplification and Response to Neoadjuvant Anti-HER2 Treatment in Early HER2-Positive Breast Cancer.

Thumbnail Image
1.- FGFR1 Amplification and Response to Neoadjuvant.pdf (261.54 KB)
Identifiers
URI: http://hdl.handle.net/10641/2854
ISSN: 1999-4923
DOI: 10.3390/pharmaceutics14020242

Publication date

2021

Start date of the public exhibition period

End date of the public exhibition period

Authors

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Metrics
Google Scholar
Share
Export

Research Projects

Organizational Units

Journal Issue

Doctoral program

Description

Keywords

HER2-positive breast cancer, Anti-HER2 treatment, FGFR1 gene, Pathological complete response, Miller–Payne grading

Citation

Collections

FACULTAD DE MEDICINA